Heron Therapeutics, Inc. (NASDAQ: HRTX) today announced the pricing of an underwritten public offering of approximately $200 million of shares ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Equity Offerings

Heron Therapeutics Announces Pricing of Public Offering of Common StockJune 25, 2018 10:01 PM After-Hours Stock Movers 06/25: (XERS) (BLDP) (EXEL) Higher; (GEVO) (SENS) (HRTX) Lower (more...)June 25, 2018 5:46 PM Heron Therapeutics (HRTX) to Offer $200M in Common StockJune 25, 2018 4:01 PM Heron Therapeutics (HRTX) PT Raised to $80 at Evercore ISIJune 22, 2018 8:33 AM Mizuho Sees Heron Therapeutics' (HRTX) HTX-011 Receiving Approval with Broad Label In Mid-2019June 22, 2018 6:33 AM Heron Therapeutics (HRTX) PT Raised to $44 at BofA/Merrill LynchJune 22, 2018 6:31 AM Heron Therapeutics (HRTX) PT Raised to $46 at Leerink Partners; 'Focus Moving to HTX-011's Commercialization'June 22, 2018 6:12 AM Heron Therapeutics (HRTX) PT Raised to $50 at OppenheimerJune 22, 2018 1:41 AM Heron Therapeutics (HRTX) PT Raised to $41 at Mizuho SecuritiesJune 22, 2018 1:38 AM